Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983 Aug;59(694):500-3.
doi: 10.1136/pgmj.59.694.500.

Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy

R Stuart-Harris, R Buckman, I Starke, E Wiltshaw
Clinical Trial

Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy

R Stuart-Harris et al. Postgrad Med J. 1983 Aug.

Abstract

The use of cisplatin may be associated with severe nausea and vomiting. Two separate, randomized, double-blind trials, comparing the anti-emetic effect of chlorpromazine with placebo and chlorpromazine with droperidol, were conducted in patients receiving cisplatin for ovarian cancer. Chlorpromazine was statistically superior to placebo in the control of nausea and vomiting in those patients treated with chlorpromazine had significantly less nausea than with droperidol, but there were no other significant differences between chlorpromazine and droperidol. Toxicities of chlorpromazine and droperidol were similar. Chlorpromazine shows useful activity against cisplatin nausea and vomiting.

PubMed Disclaimer

References

    1. N Engl J Med. 1979 Jul 5;301(1):47 - PubMed
    1. Gynecol Oncol. 1980 Aug;10(1):55-7 - PubMed
    1. Ann Intern Med. 1981 Sep;95(3):352-9 - PubMed